Font Size: a A A
Keyword [advanced lung adenocarcinoma]
Result: 41 - 60 | Page: 3 of 7
41. Expression And Clinical Significance Of P53 And COX-2 Protein In Patients With EGFR Mutant Advanced Lung Adenocarcinoma
42. Risk Factors Of Brain Metastasis During The Course Of EGFR-TKIs Therapy For Patients With EGFR-mutated Advanced Lung Adenocarcinoma
43. Case Report Of PD-L1 Monoclonal Antibody For Treating Advanced Lung Adenocarcinoma
44. The Differences Of Efficacy Of Chemotherapy And Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor In Advanced Lung Adenocarcinoma Patients Harboring 19del And L858R Mutation
45. Comparison Of The Clinical Outcome Of Gefitinib For Advanced Lung Adenocarcinoma With Positive Epidermal Growth Factor Receptor Mutated In Exon 21 Or 19 Del Between Patients Treated With First And Second Line Therapy
46. The Application Of CD4+CD25+CD127-Treg Cell、CEA And CA125 For Therapeutic Effect Evaluations In Patients With Advanced Lung Adenocarcinoma
47. The Expression Of RASSF6 In Advanced Lung Adenocarcinoma And Its Clinical Significance
48. Clinical Study On The Effect Of Shiquan Yuzhen Decoction On Blood Coagulation Function In Patients With Advanced Lung Adenocarcinoma
49. The Clinical Observation Of Treatment Of Later Period Lung Adenocarcinoma By Treated With Modified Zhoushi Kejinyan Combined With Targeted Drug(Gefitinib)
50. The Efficacy Of Gefitinib In The Treatment Of 58 Patients With Advanced Lung Adenocarcinoma Of EGFR Mutation And TCM Cold And Fever
51. Therapeutic Analysis Of Pemetrexed Combined With Cisplatin First-line Chemotherapy In The Treatment Of Advanced Lung Adenocarcinoma In The Elderly
52. Effect Of FOXM1 On Target Therapy With EGFR Mutation In Advanced Lung Adenocarcinoma Patients And Its Expression And Biological Function In EGFR Mutant Cell Lines
53. Predicting EGFR Mutations And Overall Survival Of Advanced(ⅢB-Ⅳ)lung Adenocarcinoma Patients Based On Radiomics
54. Investigation Of The Clinical Value In Curative And The Prognosis Of CA125 In Advanced Lung Adenocarcinoma
55. Comparative Study Of Different Treatment Schemes For Advanced Lung Adenocarcinoma With Poor Physical Condition-single Drug Pemetrexed, Paclitaxel Liposome And The Best Supportive Care
56. The Study On Gene Polymorphisms Of Folate Metabolic Enzyme And Efficacy Of Pemetrexed In Patients With Advanced Lung Adenocarcinoma
57. Correlation Study Between MICA/B And EGFR Gene,its Clinicopathological Features And Prognosis In Advanced Lung Adenocarcinoma
58. Study On Distribution And Evolution Of TCM Syndrome Elements In Patients With Advanced Lung Adenocarcinoma After AP Chemotherapy
59. Clinical Research Of Yifei Prescription Combined With Bevacizumab Plus AP Regimen In The Treatment Of Advanced Lung Adenocarcinoma
60. Clinical Study Of Adding Dose Of Icotinib In The Treatment Of Advanced Lung Adenocarcinoma
  <<First  <Prev  Next>  Last>>  Jump to